ISOPP CAPhO 2025 Symposium: Apobiologix Sponsored Lunch Symposium - The Role of Innovative Biosimilars and Generics in Improving Health Equity + 2025 HOPE Awards

Interested in learning more about health equity in Canada and innovations in oncology? Please join us at the Apobiologix Symposium! Titled “The role of innovative biosimilars and generics in improving health equity + 2025 HOPE Awards”, the session will begin with exploring the current state of health equity in the Canadian oncology landscape. Flay Charbonneau, Oncology Pharmacy Director at Sunnybrook Hospital, will then share the transformative impact of innovative generics and biosimilars in oncology. Lastly, recent projects that drive innovations in oncology will be celebrated with presentations from the winners of the 5th Annual HOPE Awards.

Learning Objectives:

1. To provide a high-level overview of health equity, inclusion and accessibility in oncology, in Canada and globally.
2. To understand the role of innovative biosimilars and generics in improving health equity in Canada.
3. To showcase how various Canadian oncology pharmacists/pharmacy teams innovate in their institution to improve education, efficiency, and interprofessional programs.
4. Health equity call to action. Pharmacists will gain knowledge and understanding of the impact of innovative biosimilars and generics and how they contribute to health equity, both locally and globally.